Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EuroEyes International Eye ClinicHKSE:01846 -3.23%79 ROE % is 2.55% as of Dec. 2025, which is 76% below its 10-year median of 10.54. GuruFocus rates HKSE:01846 with a GF Score™ of 79/100 and a GF Value™ of HK$5.54 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 622 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks worse than 54.02% on this metric.
HKSE:01846'
s ROE % Range Over the Past 10 Years
Min: -0.67 Med: 10.54 Max: 58.12
Current: 4.53
During the past 10 years, EuroEyes International Eye Clinic's highest ROE % was 58.12%. The lowest was -0.67%. And the median was 10.54%.
HKSE:01846's ROE % is ranked worse than 54.02% of 622
companies
in the Healthcare Providers & Services industry
Industry Median: 5.895
vs HKSE:01846: 4.53
EuroEyes International Eye Clinic (HKSE:01846) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
EuroEyes International Eye Clinic ROE % Related Terms
EuroEyes International Eye Clinic ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's ROE % distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
EuroEyes International Eye Clinic (HKSE:01846) has a ROE % of 2.55% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on EuroEyes International Eye Clinic and its competitors. This is 76% below median its historical median of 10.54. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #336 out of 622 companies in the Healthcare Providers & Services industry, placing it in the top 54%.
Is EuroEyes International Eye Clinic's ROE % too high?
EuroEyes International Eye Clinic's current ROE % of 2.55% is 76% below median its 10-year median of 10.54. The Healthcare Providers & Services industry median ROE % is 5.90. EuroEyes International Eye Clinic's value of 2.55% is 56.7% below this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #336 out of 622 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, EuroEyes International Eye Clinic has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #336 out of 622 companies for ROE %. This places EuroEyes International Eye Clinic in the lower half of its industry. The industry median ROE % is 5.90. EuroEyes International Eye Clinic's value of 2.55% is 56.7% below this benchmark. While the company's 10-year median is 10.54 vs. the industry median of 5.90, EuroEyes International Eye Clinic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.90, based on 622 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current ROE % of 2.55% is 56.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current ROE % is 2.55%, which is 76% below median its own 10-year median of 10.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.54, compared to a current price of HK$2.40 — trading 56.7% below its estimated fair value. The current ROE % is 2.55%, which is 76% below median its 10-year median of 10.54 and 56.7% below the Healthcare Providers & Services industry median of 5.90. EuroEyes International Eye Clinic's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current ROE % is 2.55% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.40 is trading 56.7% below its estimated GF Value™ of HK$5.54.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
ROE %: 2.55% (76% below median its 10-year median of 10.54)
GF Value™: HK$5.54 vs. price of HK$2.40 (56.7% below fair value)
Industry Position: 56.7% below the Healthcare Providers & Services median (#336 of 622)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Business Description
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
79GF Score
Get the complete analysis for HKSE:01846
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
